| Product Code: ETC327865 | Publication Date: Aug 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Thailand import trend for the hepatitis vaccine market experienced a significant decline with a Compound Annual Growth Rate (CAGR) of -96.92% from 2020 to 2024. This drastic decrease in imports may indicate a shift in demand dynamics or market stability challenges within the industry.
The Thailand Hepatitis Vaccine Market addresses the growing concern over hepatitis infections in the country. Hepatitis vaccines are essential in preventing the spread of this viral infection, and they are administered to both children and adults as part of immunization programs. The market`s growth is driven by public health initiatives, increased awareness about hepatitis prevention, and the expansion of vaccination programs. Government support and partnerships with pharmaceutical companies play a significant role in ensuring the accessibility of vaccines to the population.
The Thailand Hepatitis Vaccine Market is propelled by several factors, with public health initiatives being at the forefront. The Thai government`s efforts to combat hepatitis through vaccination programs have significantly increased vaccine adoption. Additionally, growing awareness about the risks associated with hepatitis infections, including liver damage and cancer, has spurred demand for preventive measures like vaccines. The medical tourism industry in Thailand, which attracts patients from neighboring countries, has also bolstered the demand for hepatitis vaccines. Moreover, collaborations between government bodies and pharmaceutical companies to ensure vaccine accessibility and affordability are key drivers of this market`s growth.
This market faces challenges related to vaccination awareness, healthcare infrastructure, and vaccine distribution to remote areas. Public health campaigns and government initiatives are essential to overcome these challenges.
The Hepatitis Vaccine Market in Thailand faced disruptions during the pandemic as healthcare resources were redirected towards managing the COVID-19 crisis. Routine vaccination programs, including those for hepatitis, were temporarily affected. However, efforts have been made to resume vaccination programs, and there is a growing awareness of the importance of vaccination in preventing various diseases.
The Thailand Hepatitis Vaccine Market has seen significant growth in recent years, driven by rising awareness of hepatitis prevention and increasing healthcare investments. Leading players in this market include international pharmaceutical giants such as GlaxoSmithKline, Merck & Co., and Sanofi Pasteur. These companies have a strong presence in Thailand and offer a wide range of hepatitis vaccines that cater to the diverse needs of the population. Additionally, local manufacturers like Siam Bioscience have been making strides in vaccine production, contributing to the market`s competitiveness.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Hepatitis Vaccine Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Hepatitis Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Hepatitis Vaccine Market - Industry Life Cycle |
3.4 Thailand Hepatitis Vaccine Market - Porter's Five Forces |
3.5 Thailand Hepatitis Vaccine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Thailand Hepatitis Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Thailand Hepatitis Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Hepatitis Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Thailand |
4.2.2 Government initiatives to control and prevent hepatitis outbreaks |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 High cost associated with hepatitis vaccines |
4.3.2 Limited accessibility to vaccines in rural areas of Thailand |
4.3.3 Concerns regarding the safety and efficacy of vaccines among the population |
5 Thailand Hepatitis Vaccine Market Trends |
6 Thailand Hepatitis Vaccine Market, By Types |
6.1 Thailand Hepatitis Vaccine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Thailand Hepatitis Vaccine Market Revenues & Volume, By Indication, 2021-2031F |
6.1.3 Thailand Hepatitis Vaccine Market Revenues & Volume, By Hepatitis A, 2021-2031F |
6.1.4 Thailand Hepatitis Vaccine Market Revenues & Volume, By Hepatitis B, 2021-2031F |
6.2 Thailand Hepatitis Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Hepatitis Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021-2031F |
6.2.3 Thailand Hepatitis Vaccine Market Revenues & Volume, By Inactivated Vaccine, 2021-2031F |
6.3 Thailand Hepatitis Vaccine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Thailand Hepatitis Vaccine Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 Thailand Hepatitis Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.3.4 Thailand Hepatitis Vaccine Market Revenues & Volume, By Online Pharmacy, 2021-2031F |
7 Thailand Hepatitis Vaccine Market Import-Export Trade Statistics |
7.1 Thailand Hepatitis Vaccine Market Export to Major Countries |
7.2 Thailand Hepatitis Vaccine Market Imports from Major Countries |
8 Thailand Hepatitis Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate in Thailand |
8.2 Number of public health campaigns promoting vaccination |
8.3 Investment in research and development for new hepatitis vaccines |
8.4 Rate of reported hepatitis cases in the country |
8.5 Number of healthcare facilities offering hepatitis vaccination services |
9 Thailand Hepatitis Vaccine Market - Opportunity Assessment |
9.1 Thailand Hepatitis Vaccine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Thailand Hepatitis Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 Thailand Hepatitis Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Hepatitis Vaccine Market - Competitive Landscape |
10.1 Thailand Hepatitis Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Thailand Hepatitis Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |